All Immunology articles – Page 6
-
NewsThe cold virus ‘hides’ and multiplies in the tonsils and adenoids, even in people without symptoms
A study reveals that tissues such as the tonsils and adenoids can serve as hiding places for the rhinovirus, which causes the common cold. The pathogen can persist in these tissues for long periods, be transmitted unexpectedly, and trigger new outbreaks of the disease.
-
NewsMaternal RSV vaccination cuts infant hospitalization risk by over 80%, major study finds
The largest real-world study of its kind shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before birth.
-
NewsHIV treatment reduces accelerated biological ageing by nearly four years, landmark study shows
A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological ageing in people with HIV (PWH) by nearly four years, a finding that could transform how clinicians monitor HIV treatment and long-term health outcomes.
-
NewsStudy reveals new way to strengthen immunity against the flu
A new vaccine model targets epitopes, specific but distinct regions of the protein on the surface of the influenza virus. The model includes different versions of epitopes in hopes of redirecting how the immune system responds.
-
NewsAs syphilis cases rise, study links infection with higher risk of stroke, heart attack and other serious cardiovascular problems
Adults with later-stage syphilis are more likely to develop major cardiovascular problems – including stroke, heart attack or aortic aneurysm – than similar patients without the infection. The increased risk is primarily found in those whose infection progressed longer than a year.
-
NewsStudy reveals genome-wide host–virus genetic interactions in cancer risk
Researchers report a major advance in understanding how interactions between human and viral genomes shape disease risk. They found that variations in the Epstein–Barr virus, together with a specific immune-related gene (HLA-A*11:01), strongly influence the risk of nasopharyngeal cancer.
-
NewsIn developing immunity to allergens, a little ‘dirty’ goes a long way
Exposure to diverse microbes and proteins early in life creates broad immune memory and a specific antibody that helps block allergic reactions later in life. Rather than overreacting to harmless allergens, an experienced immune system responds in a balanced way.
-
NewsA closer look at immune ‘memory’ - and how long it lasts
A new review shares recent advances from the field of immune memory and highlights key steps we might take to develop even more effective, longer-lasting immunity against deadly diseases.
-
NewsResearchers uncover how obesity impairs vaccine response
New findings reveal that obesity significantly impaired the quality and longevity of antibody responses to a Pseudomonas aeruginosa vaccine in a mouse model. The impaired antibody production was due to defects in germinal centers.
-
NewsTwo research projects to study immune responses to dengue and Zika viruses
Dr. James Earnest, an assistant professor at the Burnett School of Biomedical Sciences, is leading two new research projects to examine how humans build an immune response to dengue and the Zika virus over time, in pursuit of creating better preventative measures.
-
NewsSibling stem cell transplant linked to long-term HIV remission
Long-term HIV remission has been achieved in a patient following a stem cell transplant from a sibling carrying a certain genetic mutation, according to new research.
-
NewsResearchers explore potential link between COVID-19 and lung cancer risk
New findings have identified a potential association between COVID-19 and increased lung cancer risk, driven by underlying biological mechanisms in the lung. The study integrates human clinical data with mechanistic research in animal and cellular models.
-
NewsNanodisc platform improves vaccine design for Ebola, HIV and more
Scientists have created a platform that allows viral surface proteins to be studied in a form that more closely resembles how they appear naturally, utilizing nanodisc technology where these proteins are embedded into particles made of lipid molecules, preserving them in a membrane-like structure.
-
NewsTrial assesses safety and effectiveness of two new TB vaccines
Two new vaccines to prevent tuberculosis (TB) are safe for use in adults and children, but they do not offer protection against all forms of TB, finds a large trial from India.
-
NewsImmunogenicity and safety of an Escherichia coli-produced 9-valent HPV vaccine in adolescents compared with young women
Based on new findings, the National Medical Products Administration of China has approved a two-dose immunization schedule for the domestically produced 9-valent HPV vaccine in girls aged 9 to 17 years.
-
NewsA smarter way to build vaccines: scientists harness AI to target emerging alphaviruses
Scientists have developed a new computational pipeline that could dramatically accelerate the development of vaccines against a group of mosquito-borne viruses known as alphavirus.
-
NewsPueraria lobata decoction-derived vesicle-like nanoparticles reveal a novel mechanism for ulcerative colitis treatment
By simulating the traditional decoction process, researchers successfully isolated structurally intact GGD-PDVLNs from dried Pueraria lobata after boiling. These nanoparticles demonstrated remarkable stability in simulated gastric acid and intestinal fluids.
-
NewsPhase I study for human monoclonal antibody for Lyme disease demonstrates safety, tolerability, pharmacokinetics
A Phase I clinical trial of a human monoclonal antibody discovered and developed for the prevention of Lyme disease in the U.S. was well tolerated and showed lasting serum concentrations in participants, according to data.
-
NewsThree-dimensional microscopy reveals how tick-borne virus replicates
Researchers show how tick‑borne viruses remodel human cells into virus factories, using an advanced microscopy method. The findings provide new insight into how the virus replicates and matures, knowledge that may become important for future treatments against TBE.
-
NewsBlood test using artificial intelligence paves the way for early diagnosis of leprosy
A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil. The method showed potential for identifying the disease in its initial stages, when symptoms are subtle and traditional laboratory tests often fail.